Sertoli-Leydig cell tumor (arrhenoblastoma) in adolescent age group

Swarnalata Samal, Amogh Chimote, Rohit Juneja, Madhuprita Agrawal


Arrhenoblastoma, also known as Sertoli-Leydig cell tumors or androblastomas, are very rare neoplasm of the ovaries, resulting in the overproduction of the male hormone testosterone. This is a rare tumour which accounts for less than 0.5% of all ovarian tumours. These tumours are found in women of all age groups, but are most common in young women. Presence of an ovarian tumour plus hormonal disturbances suggests a Sertoli-Leydig cell tumour. Patients present with a recent history of progressive masculinisation. Masculinisation is preceded by anovulation, oligomenorrhoea, amenorrhoea and defeminisation. Arrhenoblastomas are generally unilateral benign tumour; do not normally spread beyond the ovary, occurring in reproductive age. This work summarizes the morphological and immunohistochemical characteristics of this tumour in a 15-year old girl with clinical signs of virilisation. A 14 year old female admitted with abdominal distension, change in voice, male pattern balding and clitoromegaly in the dept. of Ob/Gy A.V.B.R.H. (Acharya Vinoba Bhave Rural Hospital) Sawangi, Wardha. Investigations included Sonography C.T scan, ascetic tap, Serum testosterone was done. She was managed by exploratory Laparotomy and follow up was advised. On follow up her serum testosterone levels and sonography was done. Here we are representing the case.


Sertoli-Leydig cell tumor, Ferriman-Galleway scoring, Hirsutism, Virilisation

Full Text:



Scully RE. Sex cord-stromal tumours. In: Bluestein A, Ed .Pathology of the female genital tract. New York: Springer-Verlag.

Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF, Woodcock AS. Sertoli- Leydig Cell Tumors:A Clinicopathologic Study of 34 Cases. Cancer. 1981 Jul 1;48(1):187-97.

Teilum G. Classification of testicular and ovarian androblastoma and Sertoli cell tumors. A survey of comparative studies with consideration of histogenesis, endocrinology and embryological theories. Cancer 1958; 11:769-782.

Tita P, Spina A, Briguglia G, Magro A, Gallo D, Finocchiaro C, Padova G, Pezzino V. Clinical features and hormonal characteristics in a case of ovarian Arrhenoblastoma. J Endocrinol Invest. 1996 Jul-Aug;19(7):484-7.

Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumours. A clinicopathological analysis of 207 cases. Am J Surg Pathol. 1985;9:543–569.

Zaloudek C, Norris H. Sertoli-Leydig cell tumors of the ovary. A clinicopathological study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol. 1984;8:405–418.

Puzigaća S, Prelević G, Svetenović Z, Djuricić S, Kokan Dj, Radivojević U. Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation. Srp Arh Celok Lek. 2001 May-Jun;129 Suppl 1:51-5.

Chen FY, Sheu BC, Lin MC, Chow SN, Lin HH. Sertoli-Leydig cell tumor of the ovary. J Formos Med Assoc. 2004 May;103(5):388-91.

Kataria SP, Mishra K, Dev G, Tandon R. Sertoli-Leydig cell tumor of ovary with heterologous element: a case report. Indian J Pathol Microbiol. 2005 Oct;48(4):493-5.